Perrigo (NYSE:PRGO) Stock Price Down 4.4% – Here’s What Happened

Shares of Perrigo Company plc (NYSE:PRGO) fell 4.4% during trading on Wednesday . The stock traded as low as $12.29 and last traded at $12.2830. Approximately 110,652 shares changed hands during trading, a decline of 97% from the average daily volume of 3,182,696 shares. The stock had previously closed at $12.85.

Analyst Upgrades and Downgrades

PRGO has been the subject of a number of analyst reports. Weiss Ratings upgraded Perrigo from a “sell (d-)” rating to a “sell (d)” rating in a research note on Thursday, August 6th. Zacks Research upgraded Perrigo from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Finally, Wall Street Zen raised Perrigo from a “hold” rating to a “buy” rating in a research note on Saturday. One analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Perrigo currently has a consensus rating of “Hold” and an average price target of $19.33.

Perrigo Stock Performance

The firm’s 50-day moving average price is $10.71 and its 200-day moving average price is $11.48. The company has a debt-to-equity ratio of 1.31, a current ratio of 2.32 and a quick ratio of 1.32. The stock has a market cap of $1.72 billion, a P/E ratio of -0.99, a PEG ratio of 1.44 and a beta of 0.51.

Perrigo (NYSE:PRGO) last issued its earnings results on Wednesday, August 5th. The company reported $0.50 earnings per share for the quarter, topping analysts’ consensus estimates of $0.39 by $0.11. The firm had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.02 billion. Perrigo had a negative net margin of 41.85% and a positive return on equity of 11.25%. Perrigo’s revenue for the quarter was down 3.1% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.06) earnings per share. Perrigo has set its FY 2026 guidance at 2.250-2.550 EPS. Sell-side analysts expect that Perrigo Company plc will post 2.2 earnings per share for the current fiscal year.

Perrigo Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Friday, August 28th will be given a dividend of $0.29 per share. The ex-dividend date is Friday, August 28th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 9.4%. Perrigo’s dividend payout ratio (DPR) is presently -9.27%.

Institutional Investors Weigh In On Perrigo

A number of hedge funds have recently made changes to their positions in PRGO. Price T Rowe Associates Inc. MD boosted its stake in Perrigo by 3.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 17,574,227 shares of the company’s stock valued at $244,634,000 after buying an additional 653,925 shares during the last quarter. Vanguard Group Inc. increased its stake in Perrigo by 7.9% in the 4th quarter. Vanguard Group Inc. now owns 14,983,369 shares of the company’s stock worth $208,568,000 after acquiring an additional 1,101,154 shares during the last quarter. Fuller & Thaler Asset Management Inc. raised its holdings in shares of Perrigo by 291.9% during the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 7,824,759 shares of the company’s stock worth $108,921,000 after acquiring an additional 5,828,076 shares in the last quarter. State Street Corp raised its holdings in shares of Perrigo by 9.5% during the 2nd quarter. State Street Corp now owns 7,340,323 shares of the company’s stock worth $196,134,000 after acquiring an additional 637,678 shares in the last quarter. Finally, Thompson Siegel & Walmsley LLC boosted its position in shares of Perrigo by 28.4% during the 4th quarter. Thompson Siegel & Walmsley LLC now owns 4,658,601 shares of the company’s stock valued at $64,848,000 after acquiring an additional 1,029,770 shares during the last quarter. 95.91% of the stock is currently owned by hedge funds and other institutional investors.

Perrigo Company Profile

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.